Alan W. Dunton is Director at ORAGENICS INC (OGEN). They have made 28 open-market trades across 4 companies since 2007, most recently 2026-01-26.
CIK 0001304773
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $149K since 2007, against 15 sales. Across 10 scored buys the stock is up 46.3% at ninety days, and 44.3 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +173.9% | +42.5% | +46.3% |
| Alpha | -1.4% | +42.9% | +44.3% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRMD | SELL | 2025-12-30 | 2026-01-02 | $13.00 | $260K | -41.8% | -33.0% | -42.2% |
| CRMD | SELL | 2025-09-12 | 2025-09-16 | $13.13 | $131K | -2.8% | -13.3% | -2.5% |
| OGEN | SELL | 2024-12-06 | 2024-12-09 | $0.36 | $24 | +1.6% | -9.8% | -23.0% |
| CRMD | BUY | 2023-12-14 | 2023-12-18 | $3.38 | $20K | +13.3% | +0.9% | +14.5% |
| PTN | SELL | 2023-12-04 | 2023-12-06 | $2.48 | $496 | +214.8% | +52.3% | +52.3% |
| PTN | SELL | 2022-12-21 | 2022-12-23 | $2.97 | $594 | +214.8% | +52.3% | +52.3% |
| CRMD | BUY | 2020-08-12 | 2020-08-14 | $3.95 | $20K | +7.7% | +6.1% | +30.0% |
| PTN | BUY | 2018-11-15 | 2018-11-19 | $0.78 | $8K | +214.8% | +52.3% | +52.3% |
| OGEN | SELL | 2014-03-25 | 2014-03-27 | $3.02 | $36K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2014-03-20 | 2014-03-21 | $3.03 | $6K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2014-03-10 | 2014-03-12 | $3.37 | $8K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2013-12-30 | 2013-12-31 | $2.85 | $29K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2013-12-23 | 2013-12-26 | $2.91 | $15K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2013-12-20 | 2013-12-23 | $2.86 | $29K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2013-12-17 | 2013-12-18 | $2.83 | $25K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2013-12-12 | 2013-12-13 | $3.00 | $21K | -28.0% | -1.4% | -1.4% |
| OGEN | SELL | 2013-12-09 | 2013-12-11 | $3.04 | $18K | -28.0% | -1.4% | -1.4% |
| PTN | BUY | 2013-03-19 | 2013-03-21 | $0.58 | $580 | +214.8% | +52.3% | +52.3% |
| PTN | BUY | 2013-02-01 | 2013-02-05 | $0.59 | $1K | +214.8% | +52.3% | +52.3% |
| PTN | SELL | 2012-11-16 | 2012-11-20 | $0.68 | $680 | +214.8% | +52.3% | +52.3% |
| PTN | BUY | 2012-09-04 | 2012-09-06 | $0.58 | $580 | +214.8% | +52.3% | +52.3% |
| PTN | BUY | 2012-08-28 | 2012-08-30 | $0.56 | $291 | +214.8% | +52.3% | +52.3% |
| PTN | BUY | 2012-01-11 | 2012-01-12 | $0.43 | $430 | +214.8% | +52.3% | +52.3% |
| PTN | BUY | 2011-11-16 | 2011-11-22 | $0.50 | $500 | +214.8% | +52.3% | +52.3% |
| PTN | BUY | 2011-11-03 | 2011-11-07 | $0.59 | $1K | +214.8% | +52.3% | +52.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| EPCT |
| 705,000 |
| — |
| OGEN.BC | 172,588 | — |
| Total | $604K |
Shares reported on the most recent Form 4, priced at the 2026-01-27 close. 6 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.